Does CETIRIZINE\PHENYLEPHRINE Cause Mobility decreased? 6 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Mobility decreased have been filed in association with CETIRIZINE\PHENYLEPHRINE. This represents 11.3% of all adverse event reports for CETIRIZINE\PHENYLEPHRINE.
6
Reports of Mobility decreased with CETIRIZINE\PHENYLEPHRINE
11.3%
of all CETIRIZINE\PHENYLEPHRINE reports
4
Deaths
5
Hospitalizations
How Dangerous Is Mobility decreased From CETIRIZINE\PHENYLEPHRINE?
Of the 6 reports, 4 (66.7%) resulted in death, 5 (83.3%) required hospitalization, and 6 (100.0%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CETIRIZINE\PHENYLEPHRINE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does CETIRIZINE\PHENYLEPHRINE Cause?
Glossodynia (40)
Fatigue (39)
Alopecia (38)
Arthropathy (37)
Pemphigus (37)
Rheumatoid arthritis (37)
Systemic lupus erythematosus (37)
Abdominal discomfort (36)
Drug ineffective (36)
Contraindicated product administered (34)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)